TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Vectus Biosystems Limited ( (AU:VBS) ) has provided an update.
Vectus Biosystems Limited has released its annual financial report, which includes consolidated financial statements and notes. The report, authorized by the Board of Directors, reflects the company’s financial activities and performance in Australian dollars, providing stakeholders with insights into its fiscal health and strategic direction.
More about Vectus Biosystems Limited
Vectus Biosystems Limited is a publicly listed company based in Australia, operating in the biotechnology industry. It focuses on developing therapeutic products and solutions, with a market emphasis on addressing fibrotic diseases and hypertension.
Average Trading Volume: 54,692
Technical Sentiment Signal: Sell
Current Market Cap: A$3.2M
For a thorough assessment of VBS stock, go to TipRanks’ Stock Analysis page.